Trials / Sponsors / Gene Signal SAS
Gene Signal SAS
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG Ischaemic Central Retinal Vein Occlusion, Neovascular Glaucoma | Phase 2 / Phase 3 | 2017-01-01 |